Halving the price of bionic prostheses and artificial organs
Hélice is an innovative financial engineering based on Blockchain (Polygon) that aims to halve the price of bionic prosthetics and artificial organs.
These technologies include retinal implants, prosthetic arms, neuroprosthetics, artificial hearts, exoskeletons etc.
We are frustrated by the exorbitant prices of these technologies ( ≈$100,000) and the slow pace of development in these fields.
The highly personalized nature of these devices complicates mass production, driving up prices.
Furthermore, biotechs struggle to advance innovation, as it can take them up to 10 years to generate revenue, resulting in low investments in this sector.
This is where Hélice’s engineering comes into play. Firstly, by breaking the vicious cycle through halving prices, and secondly, by generating a capital influx to accelerate the development of these technologies within our future laboratory
X handle : helice_h
We start from 0, but we will grow to 1B
Towards accelerating the science. We choose this mission, « not because it is easy, but because it is hard »
A little more about me
Hello 👋 I’m Héloïse, the founder
An internet page was a turning point for me.
At the age of 16, I came across the Wikipedia page dedicated to Fordism.
It explained how an “organizational change” had made it possible to lower car prices at the time.
What a discovery!
Until then, I thought only great scientists could disrupt a technological sector.
It was the first time I heard that there were other ways to achieve it.
So, for the undisciplined student that I was but who wanted to change the world and save lives, this quickly consumed my thoughts……. (read more on here)
Tokenomics
SMART CONTRACT ADRESS : 0xd25A8F412e126869eaC114Ff5734
Max Supply of 1 Unit
$HELICE is very rare and deflationary due to its max supply of 1 unit. We believe that the high value of the token (which will be equal to its Market Cap) will be a symbol of the project’s quality and enhance the reputation of our brand focused on the most advanced biotechnologies. Indeed, it would be devalued if the token had a value of $0.00… We believe that a perceived high value will attract more long-term investors as well as excellent partners to propel our growth.
Transaction fees and passive income (0 FEES AT THIS STAGE 
)
To finance the prostheses, Hélice applies a 2% fees on its token (buy/sell). Hélice will strive to promptly implement a mechanism (or system) with the aim of allowing the holders of its token to generate a passive income.
Buyback & Burn
The quantity of $HELICE will further decrease overtime, thanks to the buyback & burn initiated with each prosthetic sold.
Tokenomics
SMART CONTRACT ADRESS : 0xd25A8F412e126869eaC114Ff5734
0 FEES AT THIS STAGE
Roadmap
2021
First patient : Dylan
Additional partnerships
2023
First halving and first buyback & burn
2023
More than 100 patients fitted with the most advanced prostheses
2025/2026
Creation of the Hélice model
Presentation to the community
2023
Token available
2023
First milestone (Not disclosed)
2024/2025
Creation of an R&D laboratory with our partners
Roadmap
2021
Creation of the Hélice Model
First patient : Dylan
Presentation to the community
2023
Additional partnerships
2023
Token available
2023
First halving and first buyback-burn
2023/2024
More than 100 patients fitted with the most advanced prostheses
2023/2024
First milestone (not disclosed at this stage)
2025/2026
Creation of an R&D laboratory with partners
Partners
Advisors & Team (non exhaustive)
Bernard | Ph.D in Biology
Anton | Doctor of Medicine
Denis | Ph.D in Economics
Florian | Ph.D in Neurosciences
Thomas | Ph.D in Financial Engineering
Jérôme | Ph.D in Biomedical engineering
Thierry | Ph.D In Pharmaceutical Sciences
Olivier | Ph.D In Quantum Physics
Florian | Ph.D in Law
Jaime | Ph.D in Economics
Samuel I MSc In Physics
Adrien | MSc In International Finance
William I Master in International Management
Mickaël | MSc Financial Markets and Investments & Master in Management
Zackary | Advisor
Héloïse | Founder and CEO
Bernard | Ph.D in Biology
Director of the “Tissue Biology and Therapeutic Engineering” department at the IBCP (CNRS & University of Lyon).
Born in France in 1957 and trained as a chemist, before getting a phD in molecular virology in 1985 and post-doctorated for three years at the EMBL, Germany, in retroviral oncology. Then, he moved to Lyon (France) to study human retrovirology, designing HIV vaccine candidates, either therapeutic, using tat,rev or nef regulatory proteins or prophylactic, with gp140 constructs, through a permanent position at CNRS. Director of research from CNRS since 2004, he was head of a joint unit between CNRS and bioMerieux, dedicated to HIV and HCV therapeutic vaccines.
Anton | Doctor of Medicine
Doctor of Medicine thesis (hepatic surgery).
Diplomas of 3rd cycles of university studies in Marseille (Aix- Marseille II): Qualified in General Surgery, University Diploma in Anaesthesia – Intensive Care, University Diploma in Pathological Anatomy, University Diploma in Abdominal Ultrasound, University Diploma in Digestive Endoscopy.
Diplomas of 3rd cycles of university studies in Paris (Paris XI): University Diploma in Laparoscopic Abdominal Surgery (Paris School of Surgery, Kremlin-Bicètre), University Diploma in Clinical Oncology Villejuif (IGR).
Denis | Ph.D in Economics
Economist and former professional trader. After a Ph.D in economics from the University of Montpellier and training at the Wharton School, Denis was for more than 16 years a business buyer, professor of economics, specialist and researcher in behavioral finance, trainer in technical analysis and director of an import-export company. He worked as a professional trader in New York at Herzog Heine Geduld (Merrill Lynch) and E Trade for more than 6 years as an arbitrageur-strategist on derivatives, then in portfolio management and front office manager. Since 2004, Denis has been devoting himself to his vocation for teaching and proprietary trading.
Thierry | Ph.D In Pharmaceutical Sciences
1993: Pharmacist Diploma: six-year university degree in industrial pharmacy with honors at the University of Pharmacy of Marseille. 1998: Master degree in Sciences, speciality Biochemistry and genetics at the University of medecine of Marseille. 1999: Diplôme d’études approfondies: one-year degree before postgraduate studies in cellular and molecular biology at the University of medecine of Marseille.
RESEARCH : Study of chaperone proteins and thyroid hormonegenesis, contribution to the study of the action of the disulfide isomerase protein in the thyroglobulin metabolism.
Olivier | Ph.D In Quantum Physics
Passionate by science and by the universe, Olivier has obtained a PhD in quantum physics at Sorbonne Université in 2022. He has dealt with different research topics until now: particle physics and software development at CERN; foundations of quantum physics at ENS; modeling and statistics at CNRS; biology and environmental studies at AgroParisTech. Moreover, he is passionate about the crypto / blockchain ecosystem, and he is currently involved in the development of efficient crypto algorithmic bots.
Curriculum : PhD in Physics at Sorbonne Université (2019-2022).
Master in Theoretical Physics at Aix-Marseille Université (2018-2019).
Engineer School AgroParisTech (2013-2017).
Florian | Ph.D in Law
2007-2010 : Law degree (University of Toulon)
2010-2011 : Master of Law, Mention public law and private law (University of Toulon)
2011-2012 : Master of Notarial Law (University of Toulon).
2012-2016 : PhD in public law on “Taxation of non -resident foreigners in France”, very honorable mention (University of Toulon).
Jaime | Ph.D in Economics
Samuel I MSc In Physics
Master’s Degree – Magnetic Fusion Confinement Université Pierre et Marie Curie (Paris VI) 2012 – 2015
Diploma in Basic Physics International Center for Theoretical Physics Trieste, Italy 2011 – 2012
Maitrise de Physique Université Marien Ngouabi Congo 2009 – 2010
Licence de Physique Université Marien Ngouabi Congo 2008 – 2009
Adrien | MSc In International Finance
ESM IAE Metz Master 2, International Finance · (2017 – 2018)
Saint Petersburg State University of Economics. Master 1 International Management · (2016 – 2017)
Université d’Angers – Bachelor of Science in Economics and International management · (2015 – 2016).
Thomas P. I Ph.D in Financial Engineering
Princeton University, USA Sept. 2014 – January 2020 PhD, Operations Research and Financial Engineering (ORFE) Department
École normale supérieure, Cachan, France Sept. 2013 M.S. in Machine Learning and Computer Vision (MVA), Department of Mathematics
Université Paris Sud, Orsay, France Sept. 2012 M.S. in Probability and Statistics, Department of Mathematics
École normale supérieure, Cachan, France Sept. 2011 B.S in Mathematics, Department of Mathematics
Jérôme | Ph.D in Biomedical engineering
Researcher at the « Tissue Biology and Therapeutic Engineering » department at the IBCP (CNRS & University of Lyon).
Born in France in 1976 and trained as a polymer chemist, Dr. Sohier was a junior researcher in the first European tissue engineering company (IsoTis) prior to obtaining a Ph.D. in biomedical engineering from the university of Twente (Netherlands) in 2006. He then continued his studies and developments of regenerative medicine strategies in post-doctoral appointments in Nantes (Lab. of osteoarticular and dental engineering INSERM) and London (Imperial College, National Heart and Lung Institute). He has a strong interest in translating his research to patients needs and had the opportunity of participating in the creation of a startup company dedicated to bone repair, based on an innovative technology that he invented. Since 2012, he is a permanent researcher in Lyon, where he continues to develop translatable approaches to repair and regenerate various tissues, for which there are no therapeutic alternatives.
Zackary E. | Advisor
Mickaël | MSc Financial Markets and Investments & Master in Management
Passionate about finance, economics and geopolitics, Mickael graduated with a double degree in Finance and Management.
Since 2018, he developed his expertise in the investment management and advisory industry through his international experiences in Asset Management and Wealth Management among global industry top players.
Mickael is currently the Head of Sales in a world leading Private Bank.
His interest in the blockchain ecosystem as well as his exposure to cryptocurrency investments led him to become an Advisor at Hélice.
Héloïse | Founder and CEO
William I Master in International Management
Seasoned expert in digital asset management, holds a Bachelor’s degree in Economics and Finance from ASSAS Paris-II and a Master’s from NEOMA Business School. He has over three years of hands-on experience in managing private cryptocurrency funds and day trading. His familiarity with DeFi and Web 3 protocols, coupled with his strong background in economics and finance, has been instrumental in his strategic approach to investment.
Florian I Ph.D in Neurosciences
Bachelor’s degree – Biochemistry 2007-2010
Aix-Marseille University
Master’s degree – Neurosciences 2010 -2012
Aix-Marseille University
Doctor of Philosophy
Ph.D Neurosciences – Neurophysiopathology – Medical devices
2012-2016
Grenoble Alpes University
Research topic: Near-infrared illumination in Parkinson’s disease: a preclinical study.
And that’s not all !
Hélice works closely with over a dozen other experts, including scientists, researchers, economists, traders, physicists, engineers, lawyers, and more….
contact@helice-prosthesis.fr
Twitter Handle : @Helice_H
HÉLICE PROSTHESIS
